We're working on adding all of our packages. Stay tuned or get in touch if you don't see what you're looking for!
Add-OnClinical Trials & Rare Diseases
Clinical Trials & Rare Diseases
This package has 3 modules. The Clinical Trials Module has 15 tables. Preview the first five rows of each table or Explore the schema
Clinical Trials Module
15 Tables
Provides detailed information about clinical trials including interventions, trial arms, location, sponsor, trial conditions and more. Information is normalized, linked, and many relevant metadata descriptions are structured and ready for analysis.
id | trial_id | kind | label | description |
|---|---|---|---|---|
000008b4-f6e0-4ff4-9483-3369f59f6a63 | NCT01232920 | active_comparator | Mycophenolate mofetil | |
00000ebb-1ffc-43df-a496-2da813782f88 | NCT06115408 | experimental | Drug;N-Acetylcysteine | 600 mg/day oral daily |
000016ed-4a6f-4cd8-add3-5a5e5eef7a82 | NCT01798745 | experimental | Cohort D: JNJ-54452840 for 5 days | Each patient will receive JNJ-54452840 once daily for 5 days at a dose determined by the Data Monitoring Committee (daily dose not exceeding 240 mg). |
000069a7-9ab3-427f-9735-00b0a4e2cfe8 | NCT05321706 | placebo_comparator | Placebo | Participants will be randomized in a 1:1 fashion to receive a matching tablet once daily for one year. |
00007875-d528-4445-b6b0-7601068667a7 | NCT05479812 | experimental | WTX-124 monotherapy dose expansion in advanced or metastatic RCC |
Want all 353,864 rows? Let's connect you to sales.
id | trial_id | title | condition_id |
|---|---|---|---|
0 | NCT00000726 | Acquired Immunodeficiency Syndrome | 48294 |
1 | NCT00000726 | Communicable Diseases | 28178 |
2 | NCT00000726 | HIV Infections | 35016 |
3 | NCT00000726 | Immunologic Deficiency Syndromes | 28099 |
4 | NCT00000726 | Cytomegalovirus Retinitis | 283 |
Want all 332,259 rows? Let's connect you to sales.
id | trial_id | title | drug_id |
|---|---|---|---|
0 | NCT00000726 | Foscarnet | 529 |
1 | NCT00000726 | Phosphonoacetic Acid | 2823 |
2 | NCT00000179 | Haloperidol decanoate | 502 |
3 | NCT00000179 | Trazodone | 656 |
4 | NCT00000179 | Haloperidol | 502 |
Want all 298,998 rows? Let's connect you to sales.
trial_id | condition_id |
|---|---|
NCT06207370 | 21 |
NCT01306058 | 46 |
NCT00513604 | 48 |
NCT00924001 | 48 |
NCT00301509 | 61 |
Want all 305,819 rows? Let's connect you to sales.
trial_id | country |
|---|---|
NCT00000102 | United States |
NCT00000105 | United States |
NCT00000116 | United States |
NCT00000117 | United States |
NCT00000119 | United States |
Want all 345,756 rows? Let's connect you to sales.
id | trial_id | identifier | kind |
|---|---|---|---|
0 | NCT00000726 | NCT00000726 | primary |
1 | NCT00000726 | ACTG 015 | org_study_id |
2 | NCT00000726 | FDA 20D | external |
3 | NCT00000726 | 10991 | external |
4 | NCT00001302 | NCT00001302 | primary |
Want all 449,394 rows? Let's connect you to sales.
intervention_id | arm_group_id |
|---|---|
34a3fa97-9477-44e9-a16b-e30536b50591 | 000008b4-f6e0-4ff4-9483-3369f59f6a63 |
d36bea2f-1715-4e95-a574-40c2094e8c92 | 00000ebb-1ffc-43df-a496-2da813782f88 |
3987507a-3a67-4775-a6cc-5dd682e00d0f | 000016ed-4a6f-4cd8-add3-5a5e5eef7a82 |
ec298768-6952-45b0-a7bb-f2ab7d7fd879 | 000069a7-9ab3-427f-9735-00b0a4e2cfe8 |
120d41fc-b3bb-4647-a248-f0e272c8d3b7 | 00007875-d528-4445-b6b0-7601068667a7 |
Want all 543,651 rows? Let's connect you to sales.
id | trial_id | kind | title | description |
|---|---|---|---|---|
0000418e-26ed-4068-8765-000622067c44 | NCT04982380 | drug | Siliankang simulating tablets | Patients will be instructed to continue current antidiabetic treatment, which should be kept unchanged throughout the trial, and start treatment with Siliankang simulative tablets 3 tablets p.o. tid for 12 weeks. |
00004645-6318-4239-86ca-127207ead9cb | NCT01097486 | procedure | Allograft | Single Dose Allograft Surgical Implantation |
00006a6b-958b-438f-be34-fae8b88fafda | NCT06338826 | drug | TDF - 245mg or TAF -25mg associated to 3TC - 300mg or FTC - 200mg and a NNRTI or PI/r or INSTI | The study will include patients under current daily antiretroviral tritherapy not modified for ≥ 12 months must including tenofovir disoproxil fumarate (TDF) 245mg or tenofovir alafenamide fumarate (TAF -25mg) associated to lamivudine (3TC - 300mg) or emtricitabine (FTC - 200mg) and a NNRTI or PI/r or INSTI to choose from
NNRTI = efavirenz, rilpivirine, etravirine, doravirine
PI/r = atazanavir/r ou darunavir/r
INSTI = bictegravir, dolutegravir, elvitegravir/cobicistat, raltegravir |
00007b19-8b85-422b-81cb-496b74cf195c | NCT04721054 | drug | Thoracic epidural effect on heart rate in Laparoscopic Cholecystectomy (bupivacaine and lignocaine) | patients in epidural anesthesia were given epidural anesthesia and assessed for heart rate and mean arterial pressure |
000097c5-d490-44ce-bc7e-eb473e8ccd78 | NCT04417907 | drug | Perampanel 4mg | Healthy adults will take 4mg perampanel PO QD for six weeks |
Want all 408,969 rows? Let's connect you to sales.
id | intervention_id | drug_id |
|---|---|---|
0 | 8f38e770-d936-4484-9823-47910c3ec57f | 529 |
1 | cbdc0507-bfda-4f1d-b0cb-ec29a3b3eed8 | 11951 |
2 | f3a5cb19-e734-4dc6-8a68-3906fb6725e7 | 656 |
3 | 887b7097-5b00-4138-9734-2a0c9ecd083e | 502 |
4 | 7c8c40e6-872d-4dee-81e2-c48cad4e7a59 | 245 |
Want all 361,530 rows? Let's connect you to sales.
id | intervention_id | name |
|---|---|---|
0 | 72bf20ce-9e35-452a-9fb0-5278e331ffc4 | elavil plus prozac |
1 | a09d3d37-3a38-4798-bade-ac1c9d4383eb | Elavil |
2 | 88525cb1-9c27-4be5-a4c4-0057fecbb8c8 | Subutex |
3 | 88525cb1-9c27-4be5-a4c4-0057fecbb8c8 | Suboxone |
4 | f354cce2-1963-4e14-95d9-a3c8aa29ff15 | Revia |
Want all 329,299 rows? Let's connect you to sales.
id | intervention_id | product_id |
|---|---|---|
0 | 8f38e770-d936-4484-9823-47910c3ec57f | 413284 |
1 | f3a5cb19-e734-4dc6-8a68-3906fb6725e7 | 94335 |
2 | 887b7097-5b00-4138-9734-2a0c9ecd083e | 464755 |
3 | 1c9dd64d-84fd-41af-833e-01b664d9aa1c | 469533 |
4 | 86894763-b424-4483-9135-d50dbc18b2fb | 465274 |
Want all 173,424 rows? Let's connect you to sales.
trial_id | phase |
|---|---|
NCT00017381 | 0 |
NCT00091286 | 0 |
NCT00140556 | 0 |
NCT00176059 | 0 |
NCT00187941 | 0 |
Want all 161,350 rows? Let's connect you to sales.
id | trial_id | title | agency_class | lead_sponsor |
|---|---|---|---|---|
0 | NCT00000726 | National Institute of Allergy and Infectious Diseases (NIAID) | nih | 1 |
1 | NCT00001302 | National Cancer Institute (NCI) | nih | 1 |
2 | NCT00000179 | National Institute on Aging (NIA) | nih | 1 |
3 | NCT00000333 | National Institute on Drug Abuse (NIDA) | nih | 1 |
4 | NCT00000333 | Washington D.C. Veterans Affairs Medical Center | us_fed | 0 |
Want all 275,508 rows? Let's connect you to sales.
identifier | title | official_title | status | purpose | expanded_access | why_stopped | why_stopped_category_id | start_date | end_date | end_date_kind |
|---|---|---|---|---|---|---|---|---|---|---|
NCT00000102 | Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets | completed | treatment | 1 | ||||||
NCT00000105 | Vaccination With Tetanus and KLH to Assess Immune Responses. | Vaccination With Tetanus Toxoid and Keyhole Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses | terminated | 1 | Replaced by another study. | 2002-07-01 | 2012-03-01 | actual | ||
NCT00000114 | Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa | completed | treatment | 1 | 1984-05-01 | 1987-06-01 | actual | |||
NCT00000115 | Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema | completed | treatment | 1 | 1990-12-01 | 1994-06-01 | actual | |||
NCT00000116 | Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A | Clinical Trial of Docosahexaenoic Acid (DHA) in Patients With Retinitis Pigmentosa Receiving Vitamin A Treatment | completed | treatment | 1 | 1996-05-01 | 2002-09-01 | actual |
Want all 178,996 rows? Let's connect you to sales.
id | category | definition | safety_efficacy_concern |
|---|---|---|---|
1 | Business Decision | The trial has been terminated due to strategic decisions, administrative reasons, sponsor, or company decision. | 0 |
6 | Change in Medical/Clinical Practices | The drug(s) of interest might not be suitable to the disease that they were trying to treat due to changes in medical or clinical practices.
1. Surgeons stopped doing procedures
2. Additional published information on the topic since starting the study
3. Study no longer consistent with current clinical practice
| 0 |
11 | Competing Studies | The study drug(s) are having worse/futile results in similar competing trials. | 0 |
16 | Completed | Trial was successfully completed (user input was incorrectly marked as terminated). [eg. accrual was reached] | 0 |
21 | Conflict of Interest | The parties involved had conflicts of interests. | 0 |
Want all 30 rows? Let's connect you to sales.
Showing 15 of 15 tables
This add-on cannot be subscribed as a stand-alone package and must accompany a related package subscription.